Reported 0 shares, down 1 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 170000 |
| 2022-03-31 | 142000 |
| 2022-06-30 | 6000 |
| 2022-09-30 | 0 |
| 2022-12-31 | 161 |
| 2023-03-31 | 90 |
| 2023-06-30 | 60 |
| 2023-09-30 | 8 |
| 2023-12-31 | 9 |
| 2024-03-31 | 9 |
| 2024-06-30 | 7 |
| 2024-09-30 | 5 |
| 2024-12-31 | 4 |
| 2025-03-31 | 2 |
| 2025-06-30 | 0 |
| 2025-09-30 | 10 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -9 (-100.0%) | 0 | $0 | 2026-02-13 | |
| Q3 2025 | New | 9 | +9 (0.0%) | < 0.01% | $10 | 2025-11-14 | |
| Q2 2025 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2025-08-15 | |
| Q1 2025 | Reduced | 1 | -1 (-50.0%) | < 0.01% | $2 | 2025-05-15 | |
| Q4 2024 | Unchanged | 2 | 0 (0.0%) | < 0.01% | $4 | 2025-02-14 | |
| Q3 2024 | Reduced | 2 | -1 (-33.3%) | < 0.01% | $5 | 2024-11-14 | |
| Q2 2024 | Unchanged | 3 | 0 (0.0%) | < 0.01% | $7 | 2024-08-14 | |
| Q1 2024 | Reduced | 3 | -1 (-25.0%) | < 0.01% | $9 | 2024-05-15 | |
| Q4 2023 | Added | 4 | +1 (33.3%) | < 0.01% | $9 | 2024-02-13 | |
| Q3 2023 | Reduced | 3 | -18 (-85.7%) | < 0.01% | $8 | 2023-11-15 | |
| Q2 2023 | Reduced | 21 | -10 (-32.3%) | < 0.01% | $60 | 2023-08-14 | |
| Q1 2023 | Reduced | 31 | -24 (-43.6%) | < 0.01% | $90 | 2023-05-15 | |
| Q4 2022 | Added | 55 | +24 (77.4%) | < 0.01% | $161 | 2023-02-14 | |
| Q3 2022 | Reduced | 31 | -2,495 (-98.8%) | 0 | $0 | 2022-11-14 | |
| Q2 2022 | Reduced | 2,526 | -59,343 (-95.9%) | < 0.01% | $6,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 61,869 | -6,264 (-9.2%) | < 0.01% | $142,000 | 2022-05-13 | |
| Q4 2021 | Added | 68,133 | +67,102 (6508.4%) | < 0.01% | $170,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
26 managers reported PHARMACYTE BIOTECH INC COM NEW for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 194,447 | -71 | < 0.01% | $213,892 | 15 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 126,603 | -12,332 | < 0.01% | $139,277 | 16 qtrs |
| EQUITEC PROPRIETARY MARKETS LLC | Unchanged | 82,727 | 0 | 0.09% | $90,172 | 15 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 49,800 | +300 | < 0.01% | $54,282 | 9 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Added | 27,606 | +9,200 | < 0.01% | $30,367 | 7 qtrs |
| Schonfeld Strategic Advisors LLC | Added | 26,200 | +700 | < 0.01% | $28,558 | 16 qtrs |
| UBS Group AG | Added | 22,591 | +10,675 | < 0.01% | $24,624 | 16 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Unchanged | 20,299 | 0 | < 0.01% | $22,329 | 10 qtrs |
| NORTHERN TRUST CORPORATION | Unchanged | 19,208 | 0 | < 0.01% | $20,937 | 15 qtrs |
| NATIONAL BANK OF CANADA FI | Unchanged | 3,300 | 0 | < 0.01% | $3,564 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 15, 2025
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.